EntryPoint Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
EntryPoint Capital's BMY Position: Q1 2026 in Review
EntryPoint Capital opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 21,010 shares worth $1.27M. The stake represents 0.37% of the portfolio and ranks #24 among its holdings. This is a return to the name: EntryPoint Capital previously reported a position in BMY as recently as Q1 2024.
EntryPoint Capital first reported a position in BMY in Q4 2023 and has held it in 3 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- EntryPoint Capital held 21,010 shares of Bristol-Myers Squibb worth $1.27M as of Q1 2026.
- Bristol-Myers Squibb was a new EntryPoint Capital position in Q1 2026.
- Bristol-Myers Squibb made up 0.37% of EntryPoint Capital's portfolio in Q1 2026, its #24 holding.
- EntryPoint Capital first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 3 quarters since.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on EntryPoint Capital's 13F filing for Q1 2026, filed 14 May 2026.